Published July 5, 2019 | Version v1
Journal article Open

Had crural by Trichophyton violaceum: Case Report

  • 1. Hospital Santa Casa de Misericórdia de Vitória (HSCMV).
  • 2. Santa Casa de Misericórdia School of Sciences (EMESCAM)
  • 3. Laboratory of Clinical Analyzes Tommasi.

Description

Clinical case report was confirmed by mycological and technical DNA exams. Patient, feminism, 28 years old, after scraping of region with reused shavers, disseminated dissemination, multicircinated and marginalized aspect, pruritic, pustular with purulent secretion. The worsening of the clinical picture hospitalization and empirical treatment with oxacillin. In the permanence of the picture, the mycological diagnosis was suggested. Direct examination of the biological material treated with 20% potassium hidroxide, culture positive DNA, confirmed the violaceum of Trichophyton, anthropophilic dermatophyte cutaneous mycosis agent. Oral griseofulvin was instituted for more than a week and left the remaining medications, providing a cure for the patient.

Files

Filho et al.pdf

Files (708.1 kB)

Name Size Download all
md5:c1b6a59af78497f09eec8dd87a7bbbf1
708.1 kB Preview Download

Additional details

References

  • Aquino VR, Constante CC, Bakos L (2007). Frequência das dermatofitoses em exames micológicos em Hospital Geral de Porto Alegre, Brasil. An Bras Dermatol., 82(3): 239-244.
  • Bakardzhiev I, Chokoeva A, Tchernev G, Wollina U, Lotti T (2016). Tinea profunda of the genital area. Successful treatment of a rare skin disease. Dermatologyc therapy. 29 (3): 181-183.
  • Farina C, Fazil P, Imbert G, Lombardi G, Passera M, Andreoni S (2015). Trichophyton violaceum and T. soudanense: re-emerging pathogens in Italy, 2005-2013. New Microbiologica. 38: 409-415.
  • Kakourou T, Uksal U (2010). European Society for Pediatric Dermatology. European Society for Pediatric D. Guidelines for the management of tinea capitis in children. Pediatr. Dermatol. 27 (3): 2268.
  • Lana DFD, Batista BG, Alves SH, Fuentefria AM (2016). Dermatofitoses: agentes etiológicos, formas clínicas, terapêutica e novas perspectivas de tratamento. Clin. Biomed. Res. 36(4): 230-241.
  • Moraes AML, Paes RA, Holanda VL (2009). Conceitos e Métodos para a Formação de Profissionais em Laboratórios de Saúde – Micologia. (4): 400-495.
  • Peres NTA, Maranhão FCA, Rossi A, Rossi, NMM (2010). Dermatófitos: interação patógeno-hospedeiro e resistência a antifúngicos. An. Bras. Dermatol. 85 (5): 657-667.
  • Pires CA, Cruz NF, Lobato AM, Sousa PO, Carneiro FR, Mendes AM (2014). Clinical, epidemiological, and therapeutic profile of dermatophytosis. An. Bras. Dermatol. 89 (2): 259-264.
  • Rocha D, Vieira FAS (2014). Levantamento epidemiológico de infecções fúngicas de pacientes atendidos em um laboratório da região do Vale dos Sinos, RS. NewsLab. (8) 121:100.
  • Rodrigues G, Oliveira F, Pereira E, Cruz RCB. (2008). Tinea capitis em adulto por Trichophyton violaceum no Brasil: relato de um caso e revisão da literatura. An. Bras. Dermatol. 83 (6): 544-548.
  • Santos JI, Coelho MPP, Nappi BP (2002). Diagnóstico laboratorial das dermatofitoses Dermatophitosis' laboratorial diagnosis. RBAC. 34 (1): 3-6.
  • Sardana K, Kaur R, Arora P, Goyal R, Ghunawat S (2018). Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre? Indian Dermatol. Online J. 9 (2): 90–95.
  • Tauber A, Muller-Goyman CC (2014). Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model. Mol. Pharm. 2014; 11 (7): 1991-1996.
  • Van Puijenbroek EP, Duyvendak RJP, De Kock CA, Krol SJ, Jaspar AHJ, Loogman MCM (2014). Dermatomicoses, Resumo de diretriz NHG M64. 2008 - traduzido do original em holandês por Luiz F.G. Comazzetto.
  • Zoulatia G, Maigaa RY, El Haourib M, Er-ramia M (2018). Dermatophyties à Trichophyton violaceum au laboratoire de parasitologie mycologie de I'HMMI de Mekhnès (à propos de douze cas). Journal de Mycologie Médicale, 28 (1): 1-7.